• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环氧化酶-2作为一种治疗靶点。

Cyclooxygenase-2 as a therapeutic target.

作者信息

Mitchell J A, Evans T W

机构信息

Unit of Critical Care Medicine, Royal Brompton Hospital, London, UK.

出版信息

Inflamm Res. 1998 Oct;47 Suppl 2:S88-92. doi: 10.1007/s000110050287.

DOI:10.1007/s000110050287
PMID:9831329
Abstract

Cyclooxygenase (COX)-2 is the predominant COX isoform present at sites of inflammation, and produces prostaglandins (PG) that cause swelling and pain. However, in situations where the release of protective PGs by COX-1 has been lost, the induction of COX-2 may compensate and reduce inflammatory responses. This is particularly likely in large blood vessels, where, under physiological conditions, the release of prostacyclin by COX-1, present in the endothelium, is an important component of cardiovascular homeostasis. We, and others, have recently shown that COX-2 can be induced by proinflammatory cytokines in human blood vessels, and also in human airway cells. Moreover, recent data from our group have suggested that in these structures, COX-2 is anti-inflammatory at the level of cellular proliferation, adhesion receptor expression, and cytokine release.

摘要

环氧化酶(COX)-2是炎症部位主要存在的COX同工型,可产生导致肿胀和疼痛的前列腺素(PG)。然而,在COX-1释放保护性PG的功能丧失的情况下,COX-2的诱导可能会起到补偿作用并减轻炎症反应。这在大血管中尤为可能,在生理条件下,内皮中存在的COX-1释放前列环素是心血管稳态的重要组成部分。我们和其他人最近表明,COX-2可由促炎细胞因子在人体血管以及人气道细胞中诱导产生。此外,我们小组最近的数据表明,在这些结构中,COX-2在细胞增殖、黏附受体表达和细胞因子释放水平上具有抗炎作用。

相似文献

1
Cyclooxygenase-2 as a therapeutic target.环氧化酶-2作为一种治疗靶点。
Inflamm Res. 1998 Oct;47 Suppl 2:S88-92. doi: 10.1007/s000110050287.
2
Anti-inflammatory drugs and their mechanism of action.抗炎药物及其作用机制。
Inflamm Res. 1998 Oct;47 Suppl 2:S78-87. doi: 10.1007/s000110050284.
3
COX-1 and COX-2 in health and disease.健康与疾病中的COX-1和COX-2
J Am Osteopath Assoc. 1999 Nov;99(11 Suppl):S7-12.
4
Dual acting anti-inflammatory drugs: a reappraisal.双效抗炎药物:重新评估
Pharmacol Res. 2001 Dec;44(6):437-50. doi: 10.1006/phrs.2001.0872.
5
The advent of highly selective inhibitors of cyclooxygenase--a review.环氧化酶高选择性抑制剂的问世——综述
Prostaglandins Other Lipid Mediat. 1998 Aug;56(5-6):341-61. doi: 10.1016/s0090-6980(98)00064-1.
6
Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.器官培养中大鼠主动脉一氧化氮合酶和环氧化酶诱导的特征分析。
Br J Pharmacol. 1997 May;121(1):125-33. doi: 10.1038/sj.bjp.0701100.
7
The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors.COX-1和COX-2在哮喘发病机制中的作用及其在选择性抑制剂使用中的意义。
Clin Exp Allergy. 2002 Mar;32(3):339-42. doi: 10.1046/j.1365-2222.2002.01333.x.
8
COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.肠道中的COX-1和COX-2产物:COX-2抑制剂的治疗作用
Gut. 2000 Sep;47(3):320-5. doi: 10.1136/gut.47.3.320.
9
Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity.环氧化酶1在大鼠和小鼠中参与炎症反应:对胃肠道毒性的影响。
Gastroenterology. 1998 Jul;115(1):101-9. doi: 10.1016/s0016-5085(98)70370-1.
10
Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.选择性环氧化酶-2抑制剂与双效抗炎药:批判性评论
Curr Med Chem. 2002 May;9(10):1033-43. doi: 10.2174/0929867024606650.

引用本文的文献

1
Prostaglandin E regulates senescence and post-senescence neoplastic escape in primary human keratinocytes.前列腺素E调节原代人角质形成细胞的衰老和衰老后肿瘤逃逸。
Aging (Albany NY). 2024 Nov 18;16(21):13201-13224. doi: 10.18632/aging.206149.
2
Antiinflammatory Medicinal Plants from the Ugandan Greater Mpigi Region Act as Potent Inhibitors in the COX-2/PGH Pathway.乌干达大姆皮吉地区的抗炎药用植物在COX-2/PGH途径中作为强效抑制剂发挥作用。
Plants (Basel). 2021 Feb 12;10(2):351. doi: 10.3390/plants10020351.
3
Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system.
心血管系统中的类二十烷酸、前列环素和环氧化酶。
Br J Pharmacol. 2019 Apr;176(8):1038-1050. doi: 10.1111/bph.14167. Epub 2018 Apr 14.
4
Cyclooxygenase-2 Selectively Controls Renal Blood Flow Through a Novel PPARβ/δ-Dependent Vasodilator Pathway.环氧化酶-2 通过新型 PPARβ/δ 依赖性血管舒张途径选择性控制肾血流。
Hypertension. 2018 Feb;71(2):297-305. doi: 10.1161/HYPERTENSIONAHA.117.09906. Epub 2018 Jan 2.
5
Synthesis, Anti-Inflammatory and Anti- Nociceptive Activities and Cytotoxic Effect of Novel Thiazolidin-4-ones Derivatives as Selective Cyclooxygenase (COX-2) Inhibitors.新型噻唑烷-4-酮衍生物的合成、抗炎和抗伤害感受活性及细胞毒性作为选择性环氧化酶(COX-2)抑制剂。
Iran J Basic Med Sci. 2013 Dec;16(12):1238-44.
6
Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells.肥大细胞和蛋白酶激活受体-2在尿路上皮细胞环氧化酶-2表达中的作用。
Am J Physiol Regul Integr Comp Physiol. 2009 Oct;297(4):R1127-35. doi: 10.1152/ajpregu.00310.2009. Epub 2009 Aug 12.
7
Present status and strategy of NSAIDs-induced small bowel injury.非甾体抗炎药诱导的小肠损伤的现状与策略。
J Gastroenterol. 2009;44(9):879-88. doi: 10.1007/s00535-009-0102-2. Epub 2009 Jul 1.
8
Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy.胶囊内镜诊断非甾体抗炎药所致肠病
J Gastroenterol. 2009;44 Suppl 19:64-71. doi: 10.1007/s00535-008-2248-8. Epub 2009 Jan 16.
9
Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk.环氧化酶抑制对THP-1人巨噬细胞中胆固醇流出蛋白及动脉粥样硬化泡沫细胞转化的影响:心血管风险增加的一种可能机制
Arthritis Res Ther. 2007;9(1):R4. doi: 10.1186/ar2109.
10
Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor alpha-dependent repression of cyclin D1.基于尿素的链烷酸通过过氧化物酶体增殖物激活受体α依赖性抑制细胞周期蛋白D1来抑制平滑肌增殖。
Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2462-8. doi: 10.1161/01.ATV.0000242013.29441.81. Epub 2006 Aug 17.